Insights

Loading spinner
Gathering insights about Xilio Therapeutics, Inc.

Similar companies to Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. Tech Stack

Xilio Therapeutics, Inc. uses 8 technology products and services including jQuery CDN, WordPress, CookieYes, and more. Explore Xilio Therapeutics, Inc.'s tech stack below.

  • jQuery CDN
    Content Delivery Network
  • WordPress
    Content Management System
  • CookieYes
    Cookie Compliance
  • MySQL
    Database
  • Jupyter
    File Sharing
  • Microsoft Word
    Office Suites
  • Airtable
    Project Management
  • Bootstrap
    UI Frameworks

Media & News

Xilio Therapeutics, Inc.'s Email Address Formats

Xilio Therapeutics, Inc. uses at least 1 format(s):
Xilio Therapeutics, Inc. Email FormatsExamplePercentage
FLast@xiliotx.comJDoe@xiliotx.com
49%
LFirst@xiliotx.comDJohn@xiliotx.com
1%
FiLast@xiliotx.comJoDoe@xiliotx.com
1%
FLast@xiliotx.comJDoe@xiliotx.com
49%

Frequently Asked Questions

What is Xilio Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Xilio Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Xilio Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc. is a publicly traded company; the company's stock symbol is XLO.

What is Xilio Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc.'s official website is xiliotx.com and has social profiles on LinkedInCrunchbase.

What is Xilio Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Xilio Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Xilio Therapeutics, Inc. has approximately 90 employees across 2 continents, including North AmericaEurope. Key team members include Cio: N. M.Chief Financial Officer And Chief Operating Officer: C. F.Chief Scientific Officer: C. U. B.. Explore Xilio Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Xilio Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Xilio Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc.'s tech stack includes jQuery CDNWordPressCookieYesMySQLJupyterMicrosoft WordAirtableBootstrap.

What is Xilio Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc.'s email format typically follows the pattern of FLast@xiliotx.com. Find more Xilio Therapeutics, Inc. email formats with LeadIQ.

How much funding has Xilio Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Xilio Therapeutics, Inc. has raised $50M in funding. The last funding round occurred on Jun 02, 2025 for $50M.

When was Xilio Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Xilio Therapeutics, Inc. was founded in 2016.

Xilio Therapeutics, Inc.

Biotechnology ResearchMassachusetts, United States51-200 Employees

Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
XLO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $50M

    Xilio Therapeutics, Inc. has raised a total of $50M of funding over 6 rounds. Their latest funding round was raised on Jun 02, 2025 in the amount of $50M.

  • $25M$50M

    Xilio Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $50M

    Xilio Therapeutics, Inc. has raised a total of $50M of funding over 6 rounds. Their latest funding round was raised on Jun 02, 2025 in the amount of $50M.

  • $25M$50M

    Xilio Therapeutics, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.